靶向实体瘤CAR-T细胞设计: 安全性与通用性提升策略.
Chimeric antigen receptor gene-modified T (CAR-T) cell therapy represents an immunotherapeutic approach wherein autologous T cells are genetically engineered ex vivo to express specific chimeric antigen receptors (CARs), expanded, and reinfused into patients to specifically recognize and eliminate t...
| Published in: | Chinese Journal of Cancer Biotherapy Vol. 32; no. 6; pp. 559 - 570 |
|---|---|
| Main Authors: | , , , |
| Format: | review Journal Article |
| Published: |
Editorial Office of Chinese Journal of Cancer Biotherapy
Jun2025
|
| Online Access: | View this record in EBSCOhost |